S667-119

Introduced

To amend the Federal Food, Drug, and Cosmetic Act to provide for the inspection of foreign facilities that manufacture, process, pack, or hold shrimp for consumption in the United States, and for other purposes.

119th Congress Introduced Feb 20, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To amend the Federal Food, Drug, and Cosmetic Act to provide for the inspection of foreign facilities that manufacture, process, pack, or hold shrimp for consumption in the United States, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Trade, Government Operations.

Who Benefits and How

health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section id6951a1afdcd340a39801bf1d6130bcbc: 1. Short title This Act may be cited as the Safer Shrimp Imports Act.
  • Section iddecda7a57fa7423fb31dc1f4fe438b86: 2. Shrimp manufactured, processed, packed, or held at overseas facilities Section 807 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 384c) is amended...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To amend the Federal Food, Drug, and Cosmetic Act to provide for the inspection of foreign facilities that manufacture, process, pack, or hold shrimp for consumption in the United States, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.

Key Policy Areas

Healthcare, Trade, Government Operations

Primary Purpose

This bill, To amend the Federal Food, Drug, and Cosmetic Act to provide for the inspection of foreign facilities that manufacture, process, pack, or hold shrimp for consumption in the United States, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.

Policy Domains

Healthcare Trade Government Operations

Whole bill

Identified Gains
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is
health care providers and patients: ,
Identified Costs
  • federal implementing agencies
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is
federal implementing agencies: ,
health care providers and patients: ,

Legislative Progress

Introduced
Introduced Committee Passed
Feb 20, 2025

Mrs. Hyde-Smith introduced the following bill; which was read twice …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Trade Government Operations
Actor Mappings
"secretary_of_health_and_human_services"
→ Secretary of Health and Human Services

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology